| Application no. and date | 16791420.9 (espacenet) (Federated) (European Patent Register), 20161108 | | Patent/reg. no. and date | DK/EP 3374359, 20200108 | | Publication date | 20180919 | | Priority no. and date | US 201562252726 P, 20151109, US 201662401351 P, 20160929 | | EP pub. no. and date |
EP 3374359 20180919 | | Effective date | | | Applicant/owner | AstraZeneca AB,
151 85 Södertälje, SE | | Applicant ref. no. | 1495578 | | Inventor | DOBSON, Andrew, Hornby, AstraZeneca
Charter Way
Macclesfield Cheshire SK10 2NA, GB,
GRAHAM, Mark, Andrew, AstraZeneca Charter Way
Macclesfield
Cheshire SK10 2NA, GB,
WARD, Richard, Andrew, AstraZeneca Darwin Building
Cambridge Science Park
Milton Road
Cambridge CB4 0WG, GB,
JONES, Clifford, David, c/o AstraZeneca Intellectual Property AstraZeneca
Alderley Park
Macclesfield
Cheshire SK10 4TG, GB,
SWALLOW, Steven, AstraZeneca Charter Way
Macclesfield
Cheshire SK10 2NA, GB,
MCCABE, James, Francis, AstraZeneca Charter Way
Macclesfield
Cheshire SK10 2NA, GB | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/4985 (2006.01) , A61P 35/00 (2006.01) , C07D 403/04 (2006.01) , C07D 487/04 (2006.01) | | Title | DIHYDROIMIDAZOPYRAZINONDERIVATER, DER ER NYTTIGE VED BEHANDLING AF CANCER | | Int. application no. | EP2016076932 | | Int. publication no. | WO2017080979 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
